Novo Nordisk and Deep Apple ink a deal to develop oral therapies targeting a novel GPCR for cardiometabolic diseases, ...

Hims & Hers Health Inc (NYSE: HIMS) stock fell 3.8% Tuesday after Eli Lilly and Company (NYSE: LLY) indicated it would not ...

Five months after selling a cancer drug to Lilly for up to $2.5 billion, Scorpion has debuted a successor company led by its ...

As President Donald Trump vows to bridge the drug pricing gap between the U.S. and other developed countries with his “most ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

By Priya Kalia, SciTribe and Miranda Weston-Smith, BioBeat.

Eli Lilly and Camurus have entered into partnership worth up to $870m to develop long-acting therapies in cardiometabolic ...